跳至主要内容
临床试验/NCT03925792
NCT03925792已完成不适用

Lifestyle Medicine for Enhancing Psychological Wellness in Police Officers: A Pilot Randomised Controlled Trial

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Change in the Patient Health Questionnaire (PHQ-9)

研究概览

简要总结

This study will examine the feasibility and efficacy of lifestyle medicine for the enhancement of psychological wellness in police officers. The integrative lifestyle intervention is based on the "Healthy Body Healthy Mind (HBHM)" programme developed by the University of Melbourne. It includes lifestyle psychoeducation, physical activity, nutrition and diet, relaxation/ mindfulness, and sleep. These components are weaved with psychological elements such as stress management, cognitive restructuring, motivational interviewing, and goal setting strategies that are led by clinical psychologists. While lifestyle medicine has been recognised for centuries a a mean to improve physical health, the field of lifestyle medicine in the context of mental health is still in its infancy. Nevertheless, there is increasing evidence demonstrating the efficacy of individual components of lifestyle medicine (e.g. diet, physical activities, and sleep) on mood and stress management. With a well-researched lifestyle medicine programme adopted from Australia, the research team of the Chinese University of Hong Kong has customised the intervention protocol to fit the Chinese culture, and has conducted a pilot trial to test the protocol across different communities and work populations. The investigators aim to examine the effectiveness of an integration of multiple lifestyle adjustments on psychological wellness from a holistic body-mind perspective. Acknowledging that police officers are one of hte work populations with stressful work nature, it is in a hope that lifestyle medicine would be effective to facilitate stress coping and enhance the psychological wellness of police officers in the long run.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hong Kong residents aged ≥ 18 years;
  • Cantonese language fluency;
  • Patient Health Questionnaire (PHQ-9) score ≥ 10; and
  • Willingness to provide informed consent and comply with the trial protocol.

排除标准

  • Have suicidal ideation with PHQ-9 item 9 score ≥ 2 (referral information to professional services will be provided to those who endorsed items on suicidal ideation);
  • Using medication or psychotherapy for depression;
  • Having unsafe conditions and are not recommended for exercising or a change in diet by physicians; and
  • Have major psychiatric, medical or neurocognitive disorders that make participation infeasible or interfere with the adherence to the lifestyle intervention.

结局指标

主要结局

Change in the Patient Health Questionnaire (PHQ-9)

时间窗: Baseline, 1-week post-treatment and 12-week post treatment

The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe and severe depression respectively.

次要结局

  • Change in Insomnia Severity Index (ISI)(Baseline, 1-week post-treatment and 12-week post treatment)
  • Physical activity (Fitbit Surge Fitness Superwatch)(Baseline, 1-week post-treatment and 12-week post treatment)
  • Change in Credibility-Expectancy Questionnaire (CEQ)(Baseline, 1-week post-treatment)
  • Change in Depression Anxiety Stress Scales (DASS-21)(Baseline, 1-week post-treatment and 12-week post treatment)
  • Brief Resilience Scale(Baseline, 1-week post-treatment and 12-week post treatment)
  • Short Form (Six-Dimension) Health Survey (SF-6D)(Baseline, 1-week post-treatment and 12-week post treatment)
  • Health-Promoting Lifestyle Profile (HPLP II)(Baseline, 1-week post-treatment and 12-week post treatment)
  • Change in Sheehan Disability Scale (SDS)(Baseline, 1-week post-treatment and 12-week post treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fiona YY Ho

Assistant Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验